Author Details

Остроумова, Ольга Дмитриевна

Issue Section Title File
Vol 9, No 4 (2012) Articles Diurnal blood pressure variability as a risk factor for complications of arterial hypertension
Vol 10, No 1 (2013) Articles Effect of the fixed-dose combination Ekvator on blood pressure level and cognitive functions in elderly patients with arterial hypertension
Vol 10, No 2 (2013) Articles Efficacy of irbesartan in arterial hypertension and metabolic syndrome
Vol 10, No 3 (2013) Articles Covremennye predstavleniya ob ideal'noy kombinatsii antigipertenzivnykh preparatov dlya profilaktiki insul'ta
Vol 11, No 1 (2014) Articles The value of blood pressure variability in clinical practice. Opportunities of amlodipine in reducing blood pressure variability (based on the Russian program «VARIATIONS») PDF
(Rus)
Vol 11, No 1 (2014) Articles New trends in the treatment of hypertension in 2013: the renaissance of pulse pressure PDF
(Rus)
Vol 11, No 2 (2014) Articles The benefits of candesartan usage in the treatment of arterial hypertension PDF
(Rus)
Vol 11, No 4 (2014) Articles First results of the Russian database of international prospective observational registry variability of blood pressure in patients with hypertension PDF
(Rus)
Vol 11, No 3 (2014) Articles The combination therapy in arterial hypertension: opportunities of the fixed combination of irbesartan andhydrochlorothiazide(Koaprovel’) PDF
(Rus)
Vol 12, No 2 (2015) Articles The hardness of the vessel wall in patients with arterial hypertension PDF
(Rus)
Vol 12, No 1 (2015) Articles The association of arterial hypertension and ischemic heart disease is the main problem in modern cardiology practice PDF
(Rus)
Vol 12, No 4 (2015) Articles From the choice of antihypertensive drug to the choice of fixed combinations of antihypertensive drugs: a paradigm shift PDF
(Rus)
Vol 13, No 1 (2016) Articles The role of b-blockers in treatment of hypertension, according to Russian and European experts PDF
(Rus)
Vol 12, No 4 (2015) Articles A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial PDF
(Rus)
Vol 14, No 4 (2017) Articles Markers of early target-organ brain damage in essential arterial hypertension: the search continues. Possibilities of diffusion tensor magnetic resonance imaging PDF
(Rus)
Vol 14, No 3 (2017) Articles The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations PDF
(Rus)
Vol 15, No 1 (2018) Articles Fixed combination of amlodipine and lisinopril effectiveness in hypertensive smokers PDF
(Rus)
Vol 15, No 2 (2018) Articles The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arterial hypertension of 1-2 grades in international VICTORY clinical trial PDF
(Rus)
Vol 15, No 2 (2018) Articles Stroke prevention in patients with atrial fibrillation and comorbidities PDF
(Rus)
Vol 15, No 4 (2018) Articles The role of b-blockers in the new revision of the 2018 European guidelines for the diagnosis and treatment of arterial hypertension in the patients with comorbidities PDF
(Rus)
Vol 6, No 4 (2009) Articles Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)
Vol 6, No 4 (2009) Articles Arterial hypertension in the elderly and higher mental functions. Possibilities of an-tihypertensive therapy withArifon retard in the prevention of dementia.
Vol 16, No 3 (2019) Articles Target levels of blood pressure in the elderly and very old patients with chronic kidney disease without frailty PDF
(Rus)
Vol 16, No 2 (2019) Articles Drug-induced arterial hypertension PDF
(Rus)
Vol 16, No 4 (2019) Articles Target blood pressure levels in patients with arterial hypertension and frailty PDF
(Rus)
Vol 17, No 1 (2020) Review Evidence base regarding target levels of arterial pressure in patients after a stroke: focus on a geriatric population PDF
(Rus)
Vol 17, No 2 (2020) Original Article First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension PDF
(Rus)
Vol 17, No 2 (2020) Review COVID-19: a patient with cardiovascular disease at high risk PDF
(Rus)
Vol 17, No 3 (2020) Articles Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II PDF
(Rus)
Vol 17, No 3 (2020) Expert opinion Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19 PDF
(Rus)
Vol 18, No 1 (2021) Expert opinion Expert consensus. Effect of antihypertensive therapy on cognitive functions PDF
(Rus)
Vol 18, No 1 (2021) Original Article Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II PDF
(Rus)